Schrödinger at ACT 2026
Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website
Schrödinger takes part in 2 sessions at ACT 2026 in San Antonio. Its program centres on computer simulation as a first filter for DNA damage, using molecular dynamics to flag compounds that bind the DNA minor groove. It also covers toxicity testing and dosing schedule optimization for SGR-2921, a small molecule CDC7 inhibitor.
| Organization | ACT 2026 Attendance |
|---|---|
Schrödinger New York, NY | |
Computational chemistry software company that also develops its own drugs; presents physics-based genotoxicity screening and preclinical toxicity work. | Poster Mon Nov 16 5:00pm–6:30pm |
Instantly find 20 buyers from Schrödinger
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction